VivoSim

Beyond's analysis on VivoSim

• 2026-10-07 — FDA’s expanded allowance for non‑animal safety testing enables VivoSim’s human‑relevant models to cut drug‑development costs

Recent news mentioning VivoSim

• 2026-10-07 — VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
• 2026-09-16 — VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

Appears alongside

• FDA

Browse the full archive →